Foxp3在Treg细胞的表达与结直肠癌预后的研究进展

doi:10.11904/j.issn.1002-3070.2015.03.017

摘要/Abstract

摘要：

影响结直肠癌(Colorectal cancer,CRC)患者预后的因素除了一些临床病理学因素外,各类宿主免疫反应也成为影响预后的关键因素。因而,结直肠癌治疗方式除了传统的治疗模式之外,抗肿瘤免疫治疗逐渐成为当前治疗热点。调节性T细胞(Regulatory T,Treg)通过免疫调节机制参与免疫反应过程,并发挥重要的作用。叉头转录因子3(Forkhead box P3,Foxp3)作为调节性T细胞表达的调控因子之一,对Treg细胞通过抑制多种免疫细胞的增殖分化来发挥重要的作用。Foxp3⁺Treg细胞在结直肠癌患者中的表达与预后关系密切。该综述旨在阐明Foxp3与Treg细胞的基本特征、Foxp3⁺Treg细胞发挥肿瘤抑制性作用的机制、Foxp3在Treg细胞中表达对结直肠癌患者预后的重要意义进行阐述。

关键词: Foxp3, Treg细胞, 结直肠癌, 预后

Abstract:

In addition to the traditional treatment mode of colorectal cancer(Colorectal cancer,CRC),anti tumor immune treatment gradually becomes the focus.In addition to some clinical pathological factors which affect the prognosis of colorectal carcinoma,the host′s immune response becomes a hotspot.Treg cells involves in immune reaction through immunomodulatory mechanism.Foxp3 as a regulator of Treg plays an important role though suppress proliferation and differentiation of immune cell.The relationship between the expression of Foxp3 in Treg and prognosis in patients with colorectal cancer is closely.The review is to clarify the basic characters of Foxp3 and Treg,the mechanism of Foxp3+Treg cell,the significance between the expression of Foxp3 in Treg and the prognosis of colorectal cancer.

Key words: Foxp3, Treg cells, Colorectal cancer, Prognosis

中图分类号:

R735.3
735.4

盖云竹综述, 孙秀威审校. Foxp3在Treg细胞的表达与结直肠癌预后的研究进展[J]. 实用肿瘤学杂志, 2015, 29(3): 267-270.

GAI Yunzhu,SUN Xiuwei. The relationship between expression of Foxp3 in Treg cells with the prognosis of patients with colorectal cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(3): 267-270.

参考文献

1 Littman DR,Rudensky A.Th17 and regulatory T Cells in mediating and restraining inflammation[J].Cell,2010,140(6):845-858.
2 Roxburgh CS,McMillan DC.The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer[J].Cancer Treat Rev,2012,38(5):451-466.
3 Deschoolmeester V,Baay M,Van Marck E,et al.tumor infiltrating lymphocytes:an intriguing player in the survival of colorectal cancer patients[J].BMC Immunol,2010,11:19.
4 Marzano AV,Vezzoli P,Fanoni D,et al.Primary cutaneous T-cell lymphoma expressing FoxP3:a case report supporting the existence of malignancies of regulatory T cells[J].J Am Acad Dermatol,2009,61(2):348-355.
5 李艳杰,徐开林,潘秀英.CD4⁺T 细胞的研究进展[J].国际输血及血液学杂志,2010,33(1):80-83.
6 张勤英,朱凡,王毓明.结直肠癌患者外周血CD4~+ CD25~(high)调节性T细胞的作用[J].肿瘤基础与临床,2012,25(1):14-17.
7 Fontenot JD,Rasmussen JP,Williams LM,et al.Regulatory T cell lineag specification by the forkhead transcription factor foxp3[J].Immunity,2005,22(3):329-341.
8 Ye J,Ma C,Wang F,et al.Specific recruitment of γδ regulatory T cells in human breast cancer[J].Cancer Res,2013,73(20):6137-6148.
9 Huang Y,Liao H,Zhang Y,et al.Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers:a meta analysis[J].PLoS One,2014,9(5):e94376.
10 叶婧,吴霞,狄文,等.Foxp3在卵巢上皮性癌组织中的表达及其与预后相关性的研究[J].现代妇产科进展,2012,21(10):756-759.
11 Ladoire S,Arnould L,Mignot G,et al.Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy[J].Breast Cancer Res Treat,2011,125(1):65-72.
12 Mahmoud SM,Paish EC,Powe DG,et al.An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer[J].Breast Cancer Res Treat,2011,127(1):99-108.
13 Hinz S,Pagerols-Raluy L,Oberg HH,et al.Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer[J].Cancer Res,2007,67(17):8344-8350.
14 Tao H,Mimura Y,Aoe K,et al.Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells[J].Lung Cancer,2012,75(1):95-101.
15 盖晓东,赵丽微,历春.CD4⁺CD25⁺FOXP3⁺调节性T细胞及其亚型在结直肠癌组织中分布和临床意义的研究[J].中国免疫学杂志,2010,1(5):75-78.
16 Salama P,Phillips M,Grieu F,et al.Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer[J].J Clinical Oncology,2009,27(2):186-192.
17 Liu Z,Huang Q,Liu G,et al.Presence of FOXP3(+)Treg cells is correlated with colorectal cancer progression[J].Int J Clin Exp Med,2014,7(7):1781-1785.
18 Betts G,Jones E,Junaid S,et al.Suppression of tumour-specific CD4⁺T cells by regulatory T cells is associated with progression of human colorectal cancer[J].Gut,2012,61(8):1163-1171.
19 Katz SC,Bamboat ZM,Maker AV,et al.Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases[J].Ann Surg Oncol,2013,20(3):946-955.
20 Loddenkemper C,Schernus M,Noutsias M,et al.In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer[J].J Transl Med,2006,4(1):52-59.
21 Kim M,Grimmig T,Grimm M,et al.Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer[J].PLoS One,2013,8(1):e53630.

[1]	王晓雅,肖斌,廖扬,唐荣芝,孙朝晖,李林海. CXCR家族蛋白在不同乳腺癌亚型中的表达及临床预后分析[J]. 实用肿瘤学杂志, 2019, 33(3): 206-210.
[2]	冯越,邢丽楠,王棹,张云艳. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
[3]	白晓斌, 霍龙伟, 谢万福, 徐高峰, 王茂德. Chk1在胶质母细胞瘤中的表达及其与肿瘤生物学行为和预后生存的关联性[J]. 实用肿瘤学杂志, 2019, 33(2): 122-127.
[4]	石小康, 丁佑铭, 汪斌, 余斌, 徐雨. UBE2T在原发性肝癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(2): 128-133.
[5]	赵苏, 郑晓瑜, 朱开彬, 卜建龙, 徐世东. 肺癌完全性切除术对患者外周血中Th17/Treg细胞平衡的影响[J]. 实用肿瘤学杂志, 2019, 33(2): 142-148.
[6]	方琳, 刘超, 张纯慧, 张艳桥. 转移性结直肠癌维持治疗的研究现状与治疗策略[J]. 实用肿瘤学杂志, 2019, 33(2): 173-178.
[7]	佟广海, 田洋, 吴华星. 脂质组学在结直肠癌研究中的应用[J]. 实用肿瘤学杂志, 2019, 33(2): 179-192.
[8]	卢姣云, 张清媛. 实验室标志物在弥漫大B细胞淋巴瘤预后中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 183-187.
[9]	刘恒辰, 张新宇. Toll样受体信号通路作为结直肠癌潜在治疗靶点的研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 188-192.
[10]	赵凤娟, 王琪, 任贇虹, 韦珏伶, 黎乐群, 赵新华, 唐娟, 游雪梅. 肝癌伴抑郁患者血清CRP、hs-CRP水平变化及其对预后的影响[J]. 实用肿瘤学杂志, 2019, 33(1): 27-33.
[11]	张凤春, 江莺, 刘照南, 闫宁宁, 崔洪全, 徐迎春. 系统性炎症相关指标中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在根治性切除术后的胃癌患者的预后意义[J]. 实用肿瘤学杂志, 2019, 33(1): 34-39.
[12]	马健力, 张明辉, 姬宏飞, 徐向英. PD-L1蛋白与CD8⁺TILs联合检测在可切除肺腺癌预后评估中的临床意义[J]. 实用肿瘤学杂志, 2019, 33(1): 40-46.
[13]	杨洪波, 石洁, 叶勇, 李文成, 邓兆平. COL5A2在膀胱癌组织中的表达及其与临床病理特征和预后的相关性分析[J]. 实用肿瘤学杂志, 2019, 33(1): 52-56.
[14]	王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.
[15]	唐淑丽, 何匡邦, 张纯慧, 程佳楠, 张艳桥. 胃癌组织中miR-320a和CYLD的表达及与临床病理特征及预后的关系[J]. 实用肿瘤学杂志, 2018, 32(6): 538-544.